Literature DB >> 7353081

Adenine and hypoxanthine metabolism in phythohemagglutinin-stimulated and unstimulated human lymphocytes.

M M Müller, G Pischek, O Scheiner, H Stemberger, G Wiedermann.   

Abstract

The uptake and subsequent metabolism of adenine and hypoxanthine in phytohemagglutinin-stimulated and unstimulated peripheral human blood lymphocytes, freshly prepared or cultured, were studied. To investigate the initial step of nucleic acid metabolism the incorporation of 14C-purines into the acid soluble material was examined. No preferential uptake of adenine or hypoxanthine was observed in freshly prepared and cultured lymphocytes during an incubation of 1 h. However, cultured cells utilized approximately 1/3 of the purines compared to freshly drawn cells. Within the cells 2/3 of adenine and 1/2 of hypoxanthine were metabolized to nucleotides (mainly AMP and ADP). Incubation of lymphocytes with PHA for 1 h produced in the freshly prepared cells an increase of adenine- and hypoxanthine-uptake to 191% and 153%, in 48 h stimulated cells to 158% and 132%. There was, however, no change in the relative rates of the metabolic routes though the intracellular concentrations of nucleotides formed increased with adenine as substrate to 152% and with hypoxanthine to 161% during a 1 h stimulation. In contrast no enhanced formation of acid soluble nucleotide formation could be observed with PHA stimulation during 48 h. The increased rates of purine uptake and metabolism apparent 1 h after addition of mitogen may be due to an altered transport mechanism at the beginning of the transformation as an adaptive response to the increased requirements for the synthetic processes soon to follow. Once the lymphocytes are transformed no demand of purines is necessary and the uptake and metabolism is switched off.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353081     DOI: 10.1007/bf01013696

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  23 in total

1.  Spontaneous release of T cell receptors for alloantigens. II. Induction of antibodies to T cell receptors.

Authors:  H Ramseier
Journal:  Eur J Immunol       Date:  1975-01       Impact factor: 5.532

2.  Adenosine deaminase (ADA) activity in lymphocytes of normal individuals and patients with chronic lymphatic leukaemia.

Authors:  B Ramot; F Brok-Simoni; N Barnea; I Bank; F Holtzmann
Journal:  Br J Haematol       Date:  1977-05       Impact factor: 6.998

3.  Purine base transport in normal and mutant erythrocytes.

Authors:  M M Müller; M Kraupp; C H de Bruyn
Journal:  Hum Hered       Date:  1979       Impact factor: 0.444

Review 4.  Identification, enumeration, and isolation of B and T lymphocytes from human peripheral blood. Report of a WHO-IARC-sponsored workshop on human B and T cells, London, 15-17 July 1974.

Authors: 
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

5.  Standardization of lymphocyte transformation to phytohaemagglutinin.

Authors:  M Yamamura
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

6.  Adenine and adenosine metabolism in phytohemagglutinin (PHA) - stimulated and unstimulated normal human lymphocytes.

Authors:  K O Raivio; T Hovi
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

7.  Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia.

Authors:  S M Johnson; M E North; G L Asherson; J Allsop; R W Watts; A D Webster
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

8.  Regulation of de novo purine biosynthesis in human lymphoblasts. Coordinate control of proximal (rate-determining) steps and the inosinic acid branch point.

Authors:  M S Hershfield; J E Seegmiller
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

9.  Purine metabolism in human lymphocytes.

Authors:  M M Müller; G Pischek; O Scheiner; H Stemberger; G Wiedermann
Journal:  Blut       Date:  1979-06-18

10.  Potasssium transport in human blood lymphocytes treated with phytohemagglutinin.

Authors:  G B Segel; M A Lichtman
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.